For: | Ma C, Walters B, Fedorak RN. Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn’s disease. World J Gastroenterol 2013; 19(21): 3347-3351 [PMID: 23745038 DOI: 10.3748/wjg.v19.i21.3347] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i21/3347.htm |
Number | Citing Articles |
1 |
Shinichiro Tsurukawa, Nozomi Iwanaga, Yasumori Izumi, Atsunori Shirakawa, Chieko Kawahara, Tetsuo Shukuwa, Miwako Inamoto, Atsushi Kawakami, Kiyoshi Migita. Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still’s Disease. Case Reports in Rheumatology 2016; 2016: 1 doi: 10.1155/2016/4232657
|
2 |
Juan Camacho, Anabel Negredo, Bartolomé Carrilero, Manuel Segovia, Antonio Moreno, Francisco Pozo, Juan-Emilio Echevarría, José-Manuel Echevarría, M. Paz Sánchez-Seco, David Tarragó. Mutations in Coding and Non-Coding Regions in Varicella-Zoster Virus Causing Fatal Hemorrhagic Fever Without Rash in an Immunocompetent Patient: Case Report. Infectious Diseases and Therapy 2023; 12(11): 2621 doi: 10.1007/s40121-023-00884-0
|
3 |
Michael J. Bradshaw, Tracey A. Cho, Felicia C. Chow. Central Nervous System Infections Associated with Immunosuppressive Therapy for Rheumatic Disease. Rheumatic Disease Clinics of North America 2017; 43(4): 607 doi: 10.1016/j.rdc.2017.06.009
|
4 |
Mabel Ladino, Angelina Gasitulli, Fernando Muñoz. Evolución de pacientes con artritis idiopática juvenil en terapia biológica que cursan infección por virus varicela zoster. A propósito de 4 casos. Revista Chilena de Pediatría 2016; doi: 10.1016/j.rchipe.2016.06.001
|
5 |
Francesco Drago, Giulia Ciccarese, Alfredo Rebora, Aurora Parodi. Pityriasis rosea and pityriasis rosea‐like eruption: Can they be distinguished?. The Journal of Dermatology 2014; 41(9): 864 doi: 10.1111/1346-8138.12562
|
6 |
Justin Côté-Daigneault, Farhad Peerani, Eithne MacMahon, Emmanuel Delaporte, Jean-François Rahier, Jean-Frédéric Colombel. Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient. Inflammatory Bowel Diseases 2016; 22(10): 2538 doi: 10.1097/MIB.0000000000000902
|
7 |
Nilesh Lodhia. The Appropriate Use of Vaccines in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2014; 48(5): 395 doi: 10.1097/MCG.0000000000000086
|
8 |
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Elena Penza, Ottavia Magnani, Francesco Puppo. Infection risk associated with anti-TNF-α agents: a review. Expert Opinion on Drug Safety 2015; 14(4): 571 doi: 10.1517/14740338.2015.1009036
|
9 |
Giuseppe Murdaca, Simone Negrini, Marco Pellecchio, Monica Greco, Chiara Schiavi, Francesca Giusti, Francesco Puppo. Update upon the infection risk in patients receiving TNF alpha inhibitors. Expert Opinion on Drug Safety 2019; 18(3): 219 doi: 10.1080/14740338.2019.1577817
|
10 |
Athos Bousvaros, Ying Lu. Pediatric Inflammatory Bowel Disease. 2017; : 663 doi: 10.1007/978-3-319-49215-5_54
|
11 |
Lisa M. Sedger, Michael F. McDermott. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future. Cytokine & Growth Factor Reviews 2014; 25(4): 453 doi: 10.1016/j.cytogfr.2014.07.016
|
12 |
Fuensanta Gavilán Guirao, Julian Torre Cisneros. Infectious Complications in Biologic and Targeted Therapies. 2022; : 369 doi: 10.1007/978-3-031-11363-5_20
|
13 |
Athanasios P Desalermos, Francis A Farraye, Sharmeel K Wasan. Vaccinating the inflammatory bowel disease patient. Expert Review of Gastroenterology & Hepatology 2015; 9(1): 91 doi: 10.1586/17474124.2014.934672
|
14 |
Giuseppe Pignataro, Mauro Cataldi, Maurizio Taglialatela. Neurological risks and benefits of cytokine‐based treatments in coronavirus disease 2019: from preclinical to clinical evidence. British Journal of Pharmacology 2022; 179(10): 2149 doi: 10.1111/bph.15397
|
15 |
Justin Côté-Daigneault, Talat Bessissow, Maria Vutcovici Nicolae, Rui Nie, Alain Bitton, Peter Laszlo Lakatos, Paul Brassard. Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study. Inflammatory Bowel Diseases 2019; 25(5): 914 doi: 10.1093/ibd/izy311
|
16 |
Dora Y. Ho, Kyle Enriquez, Ashrit Multani. Herpesvirus Infections Potentiated by Biologics. Infectious Disease Clinics of North America 2020; 34(2): 311 doi: 10.1016/j.idc.2020.02.006
|
17 |
David D’Arienzo, Kailas Rumjahn Gryte, Francisco Noya, Veronique D. Morinville. Disseminated and Central Nervous System Vaccine-Strain Herpes Zoster Infection in a Teenager With Crohn’s Disease on Maintenance Adalimumab Therapy. JPGN Reports 2021; 2(2): e072 doi: 10.1097/PG9.0000000000000072
|
18 |
Samantha Zullow, Francis A. Farraye. Updates on vaccinating the inflammatory bowel disease patient. Expert Review of Gastroenterology & Hepatology 2019; 13(3): 229 doi: 10.1080/17474124.2019.1565993
|
19 |
Chandler Gill, Stasia Rouse, Ryan D. Jacobson. Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology. Current Neurology and Neuroscience Reports 2017; 17(10) doi: 10.1007/s11910-017-0785-3
|
20 |
J. Finsterer. Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab. Reumatismo 2022; 74(1) doi: 10.4081/reumatismo.2022.1474
|
21 |
Burke A. Cunha, Jeffrey Baron. The pharmacokinetic basis of oral valacyclovir treatment of herpes simplex virus (HSV) or varicella zoster virus (VZV) meningitis, meningoencephalitis or encephalitis in adults. Journal of Chemotherapy 2017; 29(2): 122 doi: 10.1179/1973947815Y.0000000065
|
22 |
|
23 |
Athos Bousvaros, Ying Lu. Pediatric Inflammatory Bowel Disease. 2023; : 765 doi: 10.1007/978-3-031-14744-9_55
|